Manimaran, D., N. Elangovan, and V. Palanisamy. “Anti-Tumorgenic Impact of Nano-Formulated Peptide HIF-Alpha Therapy by DMBA Induced Mammary Carcinoma in Rodent Type”. Jordan Journal of Pharmaceutical Sciences, vol. 17, no. 4, Dec. 2024, pp. 783-9, doi:10.35516/jjps.v17i4.2482.